• A40926: Dalbavancin Precursor for Advanced Antibacterial Ass

  2026-06-26

  A40926, the natural glycopeptide and dalbavancin precursor, empowers researchers to achieve high-sensitivity, reproducible results in MRSA and Neisseria gonorrhoeae inhibition studies. This article translates regulatory and biosynthetic insights into actionable, workflow-ready protocols and troubleshooting strategies for cutting-edge Gram-positive bacterial infection research.

• Rucaparib (AG-014699): Advanced Workflows for DNA Repair Res

  2026-06-26

  Rucaparib (AG-014699) stands out as a potent PARP1 inhibitor, empowering researchers to dissect DNA repair and radiosensitization in cancer models with unprecedented precision. New insights into spliceosome acetylation and combinatorial protocols are redefining experimental design, particularly in hard-to-treat tumors.

• SD 169 (indole-5-carboxamide): Optimizing p38 MAPK Inhibitio

  2026-06-25

  SD 169 (indole-5-carboxamide) delivers robust, selective p38α/β inhibition for translational research in diabetes and neuroregeneration. This guide distills protocol-ready strategies, advanced workflow enhancements, and troubleshooting tips—anchored in the latest structural and mechanistic breakthroughs—to help researchers drive reliable and interpretable results.

• Fucoidan Mitigates Irinotecan-Induced Steatohepatitis via Gu

  2026-06-25

  This study reveals that Fucoidan alleviates steatohepatitis triggered by Irinotecan (CPT-11) in chemotherapy, acting through restoration of the gut–liver axis and suppression of neutrophil extracellular traps (NETs). The mechanistic insights into gut barrier integrity and NETs provide a foundation for novel protective strategies against chemotherapy-induced liver injury.

• Streptavidin – Cy5: Precision Biotin Detection for Oncology

  2026-06-24

  Streptavidin – Cy5 unlocks high-sensitivity, low-background biotin detection for immunofluorescence and flow cytometry, bridging robust affinity with Cy5’s sharp emission. This guide details protocol optimizations, troubleshooting, and insights from recent breast cancer research to maximize performance in translational workflows.

• A40926 (SKU BA1486): Reliable Glycopeptide for Assay Precisi

  2026-06-23

  This article addresses real-world challenges in cell viability and antibacterial assays, illustrating how A40926 (SKU BA1486) delivers reproducible, data-driven solutions for researchers. With evidence from peer-reviewed studies and vendor benchmarks, we examine experimental design, assay performance, and vendor selection to support confident adoption of A40926 in Gram-positive infection research.

• Penicillin G Sodium: Mechanistic Edge for Translational Impa

  2026-06-23

  This thought-leadership article explores the mechanistic underpinnings, translational strategies, and experimental optimization of Penicillin G Sodium—a natural penicillin antibiotic—for researchers navigating infection models, cell barrier integrity, and the evolving demands of preclinical workflows. Integrating new mechanistic evidence, recent advances in intestinal barrier science, and comparative workflow insights from the literature, we provide actionable guidance and strategic context for maximizing reproducibility and translational value.

• Single Dose Indometacin Sodium for Acute Postoperative Pain:

  2026-06-22

  This article reviews the Cochrane analysis of single-dose oral indometacin for acute postoperative pain, highlighting its efficacy, study methodology, and implications for research and clinical protocols. The findings offer nuanced insight into the role of Indometacin Sodium in pain management and its broader relevance for anti-inflammatory research.

• QX77: Advancing Chaperone-Mediated Autophagy for Precision R

  2026-06-22

  Explore how QX77, a molecular chaperone activator, uniquely empowers chaperone-mediated autophagy and stem cell biology research. This article delivers a deeper mechanistic analysis, integrating the latest scientific evidence and practical assay guidance.

• Biotin (Vitamin B7) in Protein Biotinylation & Metabolic Res

  2026-06-21

  Biotin (Vitamin B7) stands out as an essential coenzyme and powerful labeling reagent, streamlining workflows from metabolic pathway studies to advanced protein biotinylation. Explore how APExBIO’s high-purity biotin enables robust, reproducible results, with protocol tips and troubleshooting grounded in the latest kinesin transport research.

• Paclitaxel (Taxol) in Cancer Research: Protocols and Optimiz

  2026-06-20

  Paclitaxel (Taxol) is an indispensable tool for dissecting microtubule dynamics and cell cycle arrest across cancer models. This article delivers up-to-date, evidence-backed workflows, troubleshooting strategies, and contextual insight—empowering translational researchers to maximize the impact of Paclitaxel in preclinical and mechanistic studies.

• CLK2 Drives Platinum Resistance in Ovarian Cancer via BRCA1

  2026-06-19

  This study reveals that Cdc2-like kinase 2 (CLK2) underlies platinum resistance in ovarian cancer by enhancing BRCA1-mediated DNA repair. The findings provide a mechanistic rationale for targeting DNA damage response pathways in efforts to overcome chemotherapy resistance.

• Enhanced A40926 Production via Engineered Nonomuraea Strains

  2026-06-19

  This study demonstrates a combined strategy of genetic engineering and medium optimization to significantly increase the fermentation yield of A40926, the glycopeptide dalbavancin precursor. The findings provide a robust framework for scalable antibiotic production, supporting advanced research into cell wall synthesis inhibitors and multidrug-resistant pathogens.

• Belinostat (PXD101): Applied Workflows in Epigenetic Cancer

  2026-06-18

  Belinostat (PXD101), a potent pan-HDAC inhibitor from APExBIO, enables precise modulation of gene expression and robust inhibition of cancer cell proliferation. This article delivers stepwise workflows, advanced troubleshooting, and actionable insights to optimize your epigenetic cancer research, with data-driven guidance for both in vitro and in vivo studies.

• Carvacrol (5-isopropyl-2-methylphenol): Mechanisms & Redox R

  2026-06-18

  Carvacrol, also known as 5-isopropyl-2-methylphenol, is a monoterpene phenol with established antibacterial, antioxidant, and anticancer activities. Mechanistic studies demonstrate its ability to induce cell cycle arrest and modulate ion channel redox responses. This dossier provides precise, evidence-linked parameters for research use.

447 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page